Drug
Aleglitazar
Aleglitazar: highest development phase Phase 2, developed by Roche. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Roche
Trials
| Drug | Phase | Indication |
|---|---|---|
| aleglitazar NCT01729403 | Phase 2 | Diabetes Mellitus Type 2 |
Latest
No recent events.
Follow Aleglitazar on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.